IMF SGL Team
2/20/20 20/2/20 bispecific bispecifics BiTEs camaraderie CAR T-cell therapy CelMod CURE magazine cytokine release syndrome dex dexamethasone disparities diversity GEM-CESAR GRIFFIN health equity high-risk smoldering multiple myeloma hope HR SMM Iceland immunotherapy istopmm MGUS minimal residual disease monoclonal antiboides monoclonal gammopathy of undetermined significance mrd myeloma nurse Myeloma XI overview personalized medicine precursor QOL quality of life relapse relapsed refractory RRMM satellite symposium SMM smoldering multiple myeloma support groups talquetamab teclistimab Tecvayli